Literature DB >> 2794732

The influence of transient hyperprolactinemia on hormonal parameters, oocyte recovery, and fertilization rates in in vitro fertilization.

Y Gonen1, R F Casper.   

Abstract

A detrimental effect of transient elevation of plasma prolactin (PRL) during in vitro fertilization (IVF) has not been proven; however, treatment with a dopamine agonist has been suggested. The present study was undertaken to determine if transient, midcycle hyperprolactinemia exerted a deleterious effect on the number of oocytes retrieved or on fertilization of oocytes in vitro. Fifty-three infertile patients with midcycle hyperprolactinemia (PRL greater than 20 micrograms/liter) during ovarian hyperstimulation for IVF were compared with 53 matched controls who remained normoprolactinemic. Mean (+/- SE) serum PRL levels on the day after hCG were significantly higher in the study group (29.5 +/- 1 micrograms/liter) than in the control (13.1 +/- 0.5 microgram/liter) (P less than 0.0005), whereas the mean estradiol (E2) concentrations on the same day were not significantly different (4822 +/- 287 and 4492 +/- 269 pmol/liters, respectively). Fertilization rates (72 +/- 4 and 70 +/- 4%, respectively) and the mean number of oocytes recovered (4.2 +/- 0.3 and 3.7 +/- 0.3, respectively) did not differ between the two groups. No correlation was observed between serum PRL and E2 levels, fertilization rates, or the number of oocytes retrieved in either group. Eleven patients with elevated PRL levels as a result of ovarian hyperstimulation were treated with 2.5 mg bromocriptine daily during the next IVF cycle. Serum PRL levels were significantly lower in the treated (5.6 +/- 1.8 micrograms/liter) than in the untreated cycles (35.6 +/- 3.1 micrograms/liter) (P less than 0.0005), whereas serum E2 concentrations did not differ.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2794732     DOI: 10.1007/bf01130780

Source DB:  PubMed          Journal:  J In Vitro Fert Embryo Transf        ISSN: 0740-7769


  13 in total

1.  Effects of prolactin on gametes and zygotes during in vitro fertilization in mice.

Authors:  A Fukuda; Y Noda; T Mori; C Mori; H Hashimoto; K Hoshino
Journal:  J In Vitro Fert Embryo Transf       Date:  1988-02

2.  Changes in the concentration of pituitary and steroid hormones in the follicular fluid of human graafian follicles throughout the menstrual cycle.

Authors:  K P McNatty; W M Hunter; A S MacNeilly; R S Sawers
Journal:  J Endocrinol       Date:  1975-03       Impact factor: 4.286

3.  Serum prolactin response to embryo transfer during human in vitro fertilization and embryo transfer.

Authors:  S P Boyers; G Lavy; J B Russell; M L Polan; A H DeCherney
Journal:  J In Vitro Fert Embryo Transf       Date:  1987-10

4.  Transient hyperprolactinemia during cycle stimulation: influence on the endocrine response and fertilization rate of human oocytes and effects of bromocriptine treatment.

Authors:  A Reinthaller; C Bieglmayer; J Deutinger; P Csaicsich
Journal:  Fertil Steril       Date:  1988-03       Impact factor: 7.329

5.  Metoclopramide-induced hyperprolactinemia impairs ovarian follicle maturation and corpus luteum function in women.

Authors:  A Kauppila; P Leinonen; R Vihko; P Ylöstalo
Journal:  J Clin Endocrinol Metab       Date:  1982-05       Impact factor: 5.958

6.  Periovulatory enhancement of spontaneous prolactin secretion in normal women.

Authors:  M T Buckman; G T Peake; L S Srivastava
Journal:  Metabolism       Date:  1980-08       Impact factor: 8.694

7.  Prolactin levels during the menstrual cycle.

Authors:  P Franchimont; C Dourcy; J J Legros; A Reuter; Y Vrindts-Gevaert; J R Van Cauwenberge; U Gaspard
Journal:  Clin Endocrinol (Oxf)       Date:  1976-11       Impact factor: 3.478

8.  Transient hyperprolactinemia: a correctable cause of idiopathic female infertility.

Authors:  M Ben-David; J G Schenker
Journal:  J Clin Endocrinol Metab       Date:  1983-08       Impact factor: 5.958

9.  Prolactin inhibits the steroidogenesis in midfollicular phase human granulosa cells cultured in a chemically defined medium.

Authors:  E Cutie; N A Andino
Journal:  Fertil Steril       Date:  1988-04       Impact factor: 7.329

10.  The influence of transient hyperprolactinemia on in vitro fertilization in humans.

Authors:  R Forman; S B Fishel; R G Edwards; E Walters
Journal:  J Clin Endocrinol Metab       Date:  1985-03       Impact factor: 5.958

View more
  2 in total

1.  Role of transient hyperprolactinemia in the late follicular phase of the gonadotropin-stimulated cycle.

Authors:  Shuji Takiguchi; Yasuhiko Nakamura; Yoshiaki Yamagata; Hisako Takayama; Ayako Harada; Norihiro Sugino; Hiroshi Kato
Journal:  Reprod Med Biol       Date:  2002-12-11

2.  Leuprolide acetate elevates prolactin during ovarian stimulation with gonadotropins.

Authors:  D R Meldrum; M I Cedars; F Hamilton; D Huynh; A Wisot; B Marr
Journal:  J Assist Reprod Genet       Date:  1992-06       Impact factor: 3.412

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.